IDH2 and glioblastoma: In this context, the category of diffuse astrocytoma, IDH-wild-type, corresponding to CNS WHO grades II or III but lacking glioblastoma molecular characteristics, is now considered rare and has been removed from the CNS WHO5 classification [22].